Indian pharma global expansion

Aurobindo Pharma Arm Expands MSD Pact, to Set Up $150-175 Million Facility

Business News Desk2 months ago2 months ago03 mins mins

Aurobindo Pharma’s subsidiary has announced the expansion of its strategic partnership with MSD (Merck & Co.), unveiling plans to establish a new manufacturing facility with an investment of $150-175 million. The move underscores Aurobindo’s ambition to strengthen its global footprint in pharmaceuticals, enhance production capacity, and deepen collaborations with multinational partners. The facility is expected…

Sun Pharma Shares Tumble 4% as Firm Closes in on $12-Billion Organon Acquisition. What’s Spooking Investors?

Business News Desk2 months ago2 months ago03 mins mins

Sun Pharmaceutical Industries, India’s largest drugmaker, saw its shares fall nearly 4% as news broke that the company is closing in on a $12-billion acquisition of US-based Organon. While the deal could potentially transform Sun Pharma into a global pharmaceutical powerhouse, investor sentiment has turned cautious, reflecting concerns about debt, integration risks, and market volatility….

Bank of America Expands Talent Pipeline with 4,000 New Campus Hires

Global Markets Volatile as Tensions Between U.S. and Iran Escalate

Capitalizing on the Humanoid Robotics and Physical AI Boom

Trump Administration Challenges Court Mandate on Tariff Refunds

Nissan Recalls Over 51,000 Kicks SUVs Over Critical Dashboard Display Failure

SEBI Clarifies Independent Director Eligibility for Promoter Cousins

Indian pharma global expansion

Aurobindo Pharma Arm Expands MSD Pact, to Set Up $150-175 Million Facility

Sun Pharma Shares Tumble 4% as Firm Closes in on $12-Billion Organon Acquisition. What’s Spooking Investors?